S. Mahon

Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes

F. Flanagan, E. Quinn, E. Dunne, 2020, Breast Cancer Research and Treatment.

Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancer.

N. Miller, M. Kerin, R. Glynn, 2012, Oncology reports.

The xc− cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine

S. Lam, J. Guan, A. Buckley, 2009, Cancer Chemotherapy and Pharmacology.

Primary splenic lymphoma presenting with ascites

S. Mahon, N. Healy, O. Mcanena, 2011, Rare tumors.

TOP2A amplification in the absence of that of HER-2/neu: toward individualization of chemotherapeutic practice in breast cancer.

N. Miller, M. Kerin, G. Callagy, 2011, The oncologist.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

Andrew H. Beck, Clare C. Yu, M. N. Vidya, 2021, npj Breast Cancer.

Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma.

G. Wheatley, H. Lyerly, K. McKinnon, 1998, Surgery.